Phacoemulsification Versus Phacoemulsification With Micro-bypass Stent

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 14, 2015

Primary Completion Date

August 12, 2016

Study Completion Date

August 12, 2017

Conditions
Primary Angle-Closure GlaucomaPrimary Angle Closure Without Glaucoma Damage
Interventions
DEVICE

iStent implantation

The iStent is a FDA and Health Sciences Authority (HSA) approved micro-bypass stent device that bypasses the trabecular meshwork (filtration membrane of the aqueous fluid exit pathway) and reroutes aqueous from the anterior chamber directly into canal of Schlemm and out of the eye. It lowers the intraocular pressure (IOP) by increasing the outflow of fluid from the eye from the micro-bypass. In angle closure, the lens has to be removed to create enough space for the iStent to be inserted.

Trial Locations (1)

768828

Khoo Teck Puat Hospital, Singapore

All Listed Sponsors
lead

Khoo Teck Puat Hospital

OTHER

NCT03647033 - Phacoemulsification Versus Phacoemulsification With Micro-bypass Stent | Biotech Hunter | Biotech Hunter